Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes

Nobuyiki Matoba, Tagan A. Griffin, Michele Mittman, Jeffrey D. Doran, Annette Alfsen, David C. Montefiori, Carl V. Hanson, Morgane Bornsel, Tsafrir Leket-Mor

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


CTB-MPR649-684, a translational fusion protein consisting of cholera toxin B subunit (CTB) and residues 649-684 of gp41 membrane proximal region (MPR), is a candidate vaccine aimed at blocking early steps of HIV-1 mucosal transmission. Bacterially produced CTB-MPR649-684 was purified to homogeneity by two affinity chromatography steps. Similar to gp41 and derivatives thereof, the MPR domain can specifically and reversibly self-associate. The affinities of the broadly-neutralizing monoclonal Abs 4E10 and 2F5 to CTB-MPR649-684 were equivalent to their nanomolar affinities toward an MPR peptide. The fusion protein's affinity to GM1 ganglioside was comparable to that of native CTB. Rabbits immunized with CTB-MPR649-684 raised only a modest level of anti-MPR649-684 Abs. However, a prime-boost immunization with CTB-MPR649-684 and a second MPR649-684-based immunogen elicited a more productive anti-MPR649-684 antibody response. These Abs strongly blocked the epithelial transcytosis of a primary subtype B HIV-1 isolate in a human tight epithelial model, expanding our previously reported results using a clade D virus. The Abs recognized epitopes at the N-terminal portion of the MPR peptide, away from the 2F5 and 4E10 epitopes and were not effective in neutralizing infection of CD4+ cells. These results indicate distinct vulnerabilities of two separate interactions of HIV-1 with human cells - Abs against the C-terminal portion of the MPR can neutralize CD4+-dependent infection, while Abs targeting the MPR's N-terminal portion can effectively block galactosyl ceramide dependent transcytosis. We propose that Abs induced by MPR649-684-based immunogens may provide broad protective value independent of infection neutralization.

Original languageEnglish (US)
Pages (from-to)218-229
Number of pages12
JournalCurrent HIV Research
Issue number3
StatePublished - May 2008


  • Functional non-neutralizing antibodies
  • HIV vaccine
  • Mucosal transmission
  • Prime/boost
  • Transcytosis

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology


Dive into the research topics of 'Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes'. Together they form a unique fingerprint.

Cite this